Journal of Hematology & Thromboembolic Diseases
Open Access

Acute Soft Head Syndrome in Sickle Cell Anemia: Creating a Firm Approach

Mark Drew^1*, Derek Fladeland² and Roona Sinha^{3 *}Correspondence: Mark Drew, Department of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan, Canada, Email:

Author info »

Abbreviations

SCD: Sickle Cell Disease; HbSS: Homozygous Hemoglobin SS Genotype; VOC: Vaso-occlusive crisis; ASHS: Acute Soft Head Syndrome; EDH: Epidural Hematoma; SDH: Subdural Hematoma; SGH: Subgaleal Hematoma; SCI: Silent Cerebral Infarcts; MRI: Magnetic Resonance Imaging; HbSβ+: Sickle Cell Beta Thalassemia

Introduction

Sickle Cell Disease (SCD) includes a diverse number of hemoglobinopathies, the most severe being the homozygous HbSS form [1,2]. There are many complications of SCD with guidelines and strategies for practitioner’s use [3-5]. However, none of these guidelines directly address the complication of ASHS. This uncommon finding is a cranio-vascular phenomenon with limited knowledge regarding pathophysiology and implications in pediatric patients. Our patient case represents a novel effort to accurately diagnose, effectively manage, and longitudinally observe patient outcomes in ASHS. Our aim is to increase awareness and recognition of this clinical presentation, and to provide practitioners with a structure for managing this rare complication. Written consent was obtained from the patient and his parents. A literature review was conducted utilizing database searches of MEDLINE, Embase, and Cochrane Central Register of Controlled Trials. Keywords included sickle cell disease, sickle cell anemia, osteonecrosis/bone infarction, pediatric/child/adolescent, head/scalp swelling, acute soft head syndrome. Studies were individually reviewed, including those reporting acute swelling and/or bony infarcts in patients 0-18 years. A total of 696 papers were found using these parameters. A manual review of abstracts was conducted to select relevant papers and 27 were included for full review. Approximately half of the fully reviewed papers focused on facial and orbital complications.

Case Presentation

A 14-year-old male of Nigerian descent with known HbSS genotype presented to a Canadian tertiary pediatric hospital with a suspected VOC. He presented to hospital six times with VOC in the preceeding two years despite medical therapy, including hydroxyurea, folate, and prophylactic antibiotics with confirmed compliance. One previous admission was complicated by osteomyelitis and septic arthritis to the left elbow, managed with surgical drainage and antibiotic therapy.

At the time of this index presentation, he complained of refractory pain to the lower back and was admitted to the pediatric ward at a tertiary care pediatric hospital. He showed initial symptom improvement with intravenous fluids, acetaminophen, ibuprofen, and intravenous morphine. Forty-eight hours after admission, he had an evolution of pain to the shoulders and arms. At this time, a swelling appeared on the right parietal region of the scalp. The mass was soft and fluctuant, not causing significant pain. There were no dermatologic findings at the site of swelling.

An ultrasound of the scalp showed a superficial fluid collection consistent with a Subgaleal Hematoma (SGH). To differentiate infarction versus infection, an MRI brain was performed and showed evidence of three separate calvarium lesions that were non-enhancing, with decreased T1 and increased T2 signal. Each lesion was associated with surrounding edema and fluid. Each had a variable degree of intracranial extension, with no mass effect noted (Figure 1).

The MRI report suggested that the findings were in keeping with ASHS. Additionally, several punctate areas of increased T2 signal were seen in the subcortical region of the left hemisphere consistent with remote lacunar infarction. Based on the significant intracranial and extracranial findings, the patient was given an exchange transfusion that same day, with rapid and complete resolution of clinical swelling and pain over the next 48 hours. During outpatient review of his clinical course and imaging, his hydroxyurea dosing was increased to the higher end of treatment range, and he began an ongoing exchange transfusion program every 4-6 weeks. The transfusions continued for over two years following the index presentation. The patient has had no further admissions to hospital for VOC and no additional episodes of swelling. Repeat MRI of the brain one year later showed resolution of the calvarium lesions, with overall stability of previously noted lacunar infarcts. Cerebral vasculature was otherwise normal.

Discussion

Patients with SCD can experience complications that are numerous and severe. Particular concern are the effects of neurological complications [4]. This clinical case makes known a rare complication not previously reported in Canada. It confirmed that cerebral ischemic events can predate ASHS and thus need to be considered [6].

Reports of ASHS in pediatric patients in the literature are presented as case reports, and have included Epidural Hematomas (EDH), Subdural Hematomas (SDH) or SGH as associated findings [7-10]. These complications can involve any of the cranial bones [11]. Reported cases often occur in the context of a VOC. Only one case report described frontal bone infarction in a patient with Sickle Cell Beta Thalassemia (HbSβ +) genotype [11,12]. Most cases in the literature report extracranial or intracranial extension, but this case reported both simultaneously (Figure 2).

The pathophysiologic mechanism for ASHS has been postulated in previous reports. Some have suggested cortical disruption and subsequent extravasation of blood and marrow contents into the extracranial and/or intracranial spaces leading to EDH, SDH and SGH formation. Our case shows that intracranial and extracranial complications occurred in the setting of the same infarct episode, which raises concern for inherent bone structure vulnerability in patients with the HbSS genotype. The severity and location of infarction and cortical disruption likely determines the anatomic layer affected by extravasation.

The literature review revealed a notable clustering of ASHS in adolescent males, and an impressive association with the HbSS [7-10,13-17]. Uncertainty exists as to why this occurs, but bone marrow hyperplasia [18], and chronic bony changes secondary to increased hematopoiesis [19] could promote susceptibility to calvarium infarcts with subsequent disruption of a poorly developed cortical bone structure. It is unknown if this phenomenon could be related to physiologic changes in males associated with pubertal and adolescent development.

Current guidelines for SCD outline that bone pain and infarcts can occur in most bones, but common locations are the long bones, ribs, sternum, spine, and pelvis [3]. Calvarium infarcts are exceedingly rare findings, and the associated ASHS lacks an approach for how best to be investigated and managed.

Based on our experience, ASHS should be viewed as a harbinger for neurological complications. This patient had preceding Silent Cerebral Infarcts (SCI), previously undiagnosed. Evidence of scalp swelling, tenderness, or headache warrants imaging to assess for intracranial extension, as well as SCI.

This patient showed impressive resolution of clinical swelling and pain with the aid of exchange transfusion therapy. Previous reports noted a longer hematoma resolution time of 1-2 weeks with conservative management [7,9,11,13]. During conservative management of ASHS, extracranial to intracranial progression requiring surgical intervention has occurred [7]. This occurrence, contrasted with our case, highlights the potential role for exchange transfusion in mitigating intracranial progression.

Repeat MRI brain imaging one year later demonstrated resolution of calvarium infarcts, with stabilization and non-recurrence of SCI with exchange transfusion therapy. This case provides a unique perspective on the role exchange transfusion can play in the ongoing management of patients who experience ASHS, develop associated EDH, and have underlying SCI.

Recommendations for investigating and managing ASHS

1. Magnetic Resonance Imaging (MRI) brain is the preferred imaging modality for diagnosing ASHS detecting intracranial involvement, and discovering sites of silent cerebral infarction.

2. Episodes of ASHS can include intracranial bleeding and thus require urgent neurological assessment to detect neurologic emergencies.

3. Initial steps in managing Acute Soft Head Syndrome (ASHS) should follow those strategies for VOC including hydration, pain control, and simple transfusion. In addition, in facilities that have the capacity, exchange transfusion can rapidly and effectively resolve symptoms of ASHS, decreasing risk of intracranial progression.

4. All patients with episodes of ASHS should have their chronic sickle cell anemia management escalated (i.e. increasing hydroxyurea dosing, considering exchange transfusion program).

Conclusion

This case effectively illustrates the clinical presentation of Acute Soft Head Syndrome (ASHS), and sheds light on management strategies that can optimize outcomes and potentially reduce the likelihood of subsequent intracranial sequelae. Despite variation in regional health care resources, there is utility in establishing an approach to investigating and managing Acute Soft Head Syndrome and its associated complications. These recommendations can offer health care providers an outline for application to patients with sickle cell anemia who may present with this rare syndrome.

References

1. Beck CE, Trottier ED, Kirby-Allen M, Pastore Y. Acute complications in children with sickle cell disease: Prevention and management. Paediatr Child Health. 2022;27(1):50-55.

   [Crossref] [Google Scholar] [PubMed]

2. Chakravorty S, Williams TN. Sickle cell disease: A neglected chronic disease of increasing global health importance. Arch Dis Child. 2015;100(1):48-53.

   [Crossref] [Google Scholar] [PubMed]

3. Canadian Haemoglobinopathy Association. Consensus statement on the care of patients with sickle cell disease in Canada. Version 2.0. Ottawa.

   [Google Scholar]

4. deBaun MR, Jordan LC, King AA, Schatz J, Vichinsky E, Fox CK, et al. American society of hematology 2020 guidelines for sickle cell disease: Prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv. 2020;4(8):1554-1588.

   [Crossref] [Google Scholar] [PubMed]

5. Brandow AM, Carroll CP, Creary S, Edwards-Elliott R, Glassberg J, Hurley RW, et al. American society of hematology 2020 guidelines for sickle cell disease: Management of acute and chronic pain. Blood Adv. 2020;4(12):2656-2701.

   [Crossref] [Google Scholar] [PubMed]

6. Saul D, Pollock AN. Skull bone/calvarial infarction and spontaneous epidural hematoma as cause of severe headache in the emergency department. Pediatr Emerg Care. 2017;33(12):809-810.

   [Crossref] [Google Scholar] [PubMed]

7. Nelson CE, Scarfone RJ. A teenager with sickle cell disease and scalp swelling. Pediatr Emerg Care. 2018;34(9):e168-e170.

   [Crossref] [Google Scholar] [PubMed]

8. Westphal K, Bakalemwa R, Groothuis E. Scalp swelling and headache in a 12-year-old boy. Pediatr Rev. 2021;42(5):258-261.

   [Crossref] [Google Scholar] [PubMed]

9. Al-Ansari RY, Al Harbi M, Al-Jubair N, Abdalla L. Acute soft head syndrome (Subgaleal haematoma) with periorbital oedema as a rare presentation in sickle cell disease. Eur J Case Rep Intern Med. 2020;7(10).

   [Crossref] [Google Scholar] [PubMed]

10. Zadeh C, Rameh V, Atweh LA. Acute soft head syndrome in a sickle cell disease patient. J Radiol Case Rep. 2021 ;15(4):1-6.

    [Crossref] [Google Scholar] [PubMed]

11. Foula MS, Hassan A, AlQurashi A, Alsaihati A, Sharroufna M. Spontaneous subgaleal hematoma in a patient with sickle cell disease: A case report and literature review. Clin Case Rep. 2019;7(11):2220-2224.

    [Crossref] [Google Scholar] [PubMed]

12. Garty I, Koren A, Garzozi H. Frontal and orbital bone infarctions causing periorbital swelling in patients with sickle cell anemia. Arch Ophthalmol. 1984;102(10):1486-1488.

    [Crossref] [Google Scholar] [PubMed]

13. Akodu SO, Njokanma OF, Diaku-Akinwumi IN, Ubuane PO, Adediji UO. Acute soft head syndrome in children with sickle cell anaemia in lagos, Nigeria. Indian J Hematol Blood Transfus. 2014;30(1):67-69.

    [Crossref] [Google Scholar] [PubMed]

14. Alli NA, Wainwright RD, Mackinnon D, Poyiadjis S, Naidu G. Skull bone infarctive crisis and deep vein thrombosis in homozygous sickle cell disease-case report and review of the literature. Hematology. 2007;12(2):169-174.

    [Crossref] [Google Scholar] [PubMed]

15. Okunade MA, Okpala IE, Olatunji PO, Shokunbi WA, Aken'Ova YA, Ogunsanwo BA. A review of cephalhaematoma in adult sickle cell disease patients. Afr J Med Med Sci. 1994;23(3):253-255.

    [Google Scholar] [PubMed]

16. Gudla V, Presenza T, Scattergood E, Solomon J. Multifocal calvarial infarction with epidural hemorrhage in a patient with sickle cell vaso-occlusive crisis: A case report. J Pediatric Neurol. 2022;20(03):231-234.

    [Google Scholar]

17. Resar LM, Oliva MM, Casella JF. Skull infarction and epidural hematomas in a patient with sickle cell anemia. J Pediatr Hematol Oncol. 1996;18(4):413-415.

    [Crossref] [Google Scholar] [PubMed]

18. Tolu SS, Wang K, Yan Z, Zhang S, Roberts K, Crouch AS, et al. Characterization of hematopoiesis in sickle cell disease by prospective isolation of stem and progenitor cells. Cells. 2020;9(10):2159.

    [Crossref] [Google Scholar] [PubMed]

19. Ejindu VC, Hine AL, Mashayekhi M, Shorvon PJ, Misra RR. Manifestations of musculoskeletal disease. RadioGraphics. 2007;27(4):1005-1021.